Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Virginie Kinet"'
Autor:
Anne Gallez, Gwenaël Nys, Vincent Wuidar, Isabelle Dias Da Silva, Mélanie Taziaux, Virginie Kinet, Ekaterine Tskitishvili, Agnès Noel, Jean-Michel Foidart, Géraldine Piel, Marianne Fillet, Christel Péqueux
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9718 (2023)
Estetrol (E4) is a natural estrogen with promising therapeutic applications in humans. The European Medicines Agency and the Food and Drug Administration have approved the use of 15 mg E4/3 mg drospirenone for contraceptive indication. Phase III clin
Externí odkaz:
https://doaj.org/article/b8d347b6ea9744e7ba3e63477983e725
Autor:
Vincent Tiffreau, Christine Detrembleur, Peter Van Den Bergh, Anne Renders, Virginie Kinet, André Thevenon, Etienne Allart, Thierry Lejeune
Publikováno v:
The Journal of the International Society of Physical and Rehabilitation Medicine, Vol 1, Iss 2, Pp 65-71 (2018)
Objective: The objective was to characterize the gait abnormalities in myotonic dystrophy type 1 patients. Material and Methods: Outcomes variables were kinematic and kinetic parameters, timing of muscles, mechanical work and energy cost, and the mot
Externí odkaz:
https://doaj.org/article/c872e31f3eff4be28fdd84e0816886f8
Publikováno v:
Frontiers in Genetics, Vol 4 (2013)
Cardiovascular diseases are a leading cause of morbidity and mortality in Western societies. It is now well established that microRNAs (miRNAs) are determinant regulators in various medical conditions including cardiovascular diseases. The recent dis
Externí odkaz:
https://doaj.org/article/4052e5303a3b407f9bbb2f80d09e9a71
Autor:
Péqueux, Anne Gallez, Gwenaël Nys, Vincent Wuidar, Isabelle Dias Da Silva, Mélanie Taziaux, Virginie Kinet, Ekaterine Tskitishvili, Agnès Noel, Jean-Michel Foidart, Géraldine Piel, Marianne Fillet, Christel
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 11; Pages: 9718
Estetrol (E4) is a natural estrogen with promising therapeutic applications in humans. The European Medicines Agency and the Food and Drug Administration have approved the use of 15 mg E4/3 mg drospirenone for contraceptive indication. Phase III clin
Autor:
Jan Rosing, Marie Mawet, Maud Jost, Christine Klipping, Catherine Maillard, Jonathan Douxfils, Jean-Michel Foidart, I.J.M. Duijkers, Virginie Kinet
Publikováno v:
Contraception, 102(6), 396-402. Elsevier Science
Objective: To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC). Study design: In this randomized, single centre, open-label, exploratory study, healthy women received either 15 mg estetrol/3 mg drospirenone (E4/DR
Autor:
Maud Jost, Virginie Kinet, Ingrid Duijkers, Jean-Michel Foidart, Christine Klipping, Adriana Bastidas
Publikováno v:
Contraception. 103(6)
Objective To evaluate the effects of estetrol 15 mg/drospirenone 3 mg on ovarian function. Study design Single-center, randomized, open-label, parallel study in healthy young women with proven ovulatory cycles. Participants received either estetrol 1
Autor:
Jan Rosing, Jean-Michel Foidart, Virginie Kinet, Maud Jost, Mitchell D. Creinin, Guillaume Chatel
Publikováno v:
Obstetrics & Gynecology. 133:7-7
Author(s): Creinin, Mitchell D; Rosing, Jan; Jost, Maud; Kinet, Virginie; Chatel, Guillaume; Foidart, Jean Michel
Autor:
Peter Cserjesi, Christophe Chanoine, Leonne E Philippen, Monika M Gladka, Natasja Kisters, Roel van der Nagel, Nicole Bitsch, Kanita Salic, Paula A. da Costa Martins, Servé Olieslagers, Stefanos Leptidis, Roel A. de Weger, Hamid el Azzouzi, Leon J. De Windt, Virginie Kinet, Ellen Dirkx, Paul G.A. Volders, Sandrine R.M. Seyen, Anne-Sophie Armand, Stephane Heymans, Meriem Bourajjaj, Yuka Morikawa, Thomas Thum, Stefanie Dimmeler, Gustavo J. J. Silva, Thomas Eschenhagen
Publikováno v:
Nature Cell Biology, 15(11), 1282-1293. Nature Publishing Group
Nature Cell Biology
Nature Cell Biology
Although aberrant reactivation of embryonic gene programs is intricately linked to pathological heart disease, the transcription factors driving these gene programs remain ill-defined. Here we report that increased calcineurin/Nfat signalling and dec
Autor:
Agnès Noël, Virginie Kinet, Michelle Lion, Karolien Castermans, Stéphanie Herkenne, Ingrid Struman, Silvia Blacher, Joseph Martial, Catherine Maillard
Publikováno v:
Endocrinology; Vol 152
The 16-kDa angiostatic N-terminal fragment of human prolactin (16K hPRL) has been reported to be a new potent anticancer compound. This protein has already proven its efficiency in several mouse tumor models in which it prevented tumor-induced angiog
Publikováno v:
Frontiers in Genetics, Vol 4 (2013)
Frontiers in Genetics
Frontiers in Genetics
Cardiovascular diseases are a leading cause of morbidity and mortality in Western societies. It is now well established that microRNAs (miRNAs) are determinant regulators in various medical conditions including cardiovascular diseases. The recent dis